fig1
![Progress in the treatment of NK-cell lymphoma/leukemia](https://image.oaes.cc/1142e3db-91fe-48c3-aabb-d98f40c1362b/4376.fig.1.jpg)
Figure 1. Treatment flowchart of ENKL patients. *CCRT-VIPD and CCRT-VIDL regimens are included. ♰AspaMetDex regimen is included only in relapsed or refractory ENKL patients. ‡The definition of limited stage in this flowchart is a little different from that in the conventional Lugano/Ann Arbor classification. UAT: Upper aerodigestive tract; LN: lymph node; RT: radiotherapy; DeVIC: dexamethasone, etoposide, ifosfamide, carboplatin; CR: complete response; PR: partial response; PD: progressive disease; SMILE: steroid, methotrexate, ifosfamide, L-asparaginase, etoposide; L-asp: L-asparaginase; HSCT: hematopoietic stem cell transplantation.